Human peripheral eosinophils express functional interferon-gamma receptors (IFN-γR)

Clinical and Experimental Immunology

Volumn 110, Issue 3, 1997, Pages 524-529

  Ishihara, C ^a   Ochiai, K ^a   Kagami, M ^a   Takashahi, H ^b   Matsuyama, G ^a   Yoshida, S ^b   Tomioka, H ^a   Koya, N ^a  

^a TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^b ASAHI GENERAL HOSPITAL   (Japan)

Author keywords

CD69; Eosinophilic cationic protein; Eosinophils; IFN receptor

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; GAMMA INTERFERON; INTERFERON RECEPTOR;

ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPEREOSINOPHILIC SYNDROME; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030734617     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4511469.x     Document Type: Article

References (32)

1. Trinchieri G, Perussia B. Immune Interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 1985; 6:131-6.
2. Farrar MA, Schreiber RD. The molecular cell biology of interferon-γ and its receptor. Annu Rev Immunol 1993; 11:571-611.
3. Novick D, Orchansky P, Revel M, Rubinstein M. The human interferon-γ receptor. J Biol Chem 1987; 262:8483-7.
4. Aguet M, Merlin G. Purification of human γ interferon receptors by sequential affinity chromatography on immobilized monoclonal antireceptor antibodies and human γ interferon. J Exp Med 1987; 165:988-99.
5. Calderon J, Sheehan KC, Chance C, Thomas ML Schleiber RD. Purification and characterization of the human interferon-γ receptor from placenta. Proc Natl Acad Sci USA 1988; 85:837-41.
6. Aguet M, Dembic Z, Merlin G. Molecular cloning and expression of the human IFN-γ receptor. Cell 1988; 55:273-80.
7. Mao C, Aguet M, Merlin G. Molecular characterization of the human interferon-γ receptor: analysis of polymorphism and glycosylation. J Interferon Res 1989; 9:659-69.
8. Fountoulakis M, Zuluuf M, Lustig A, Garotta G. Stoichiometry of interaction between interferon γ and its receptor. Eur J Biochem 1992; 208:781-7.
9. Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986; 39:177-253.
10. Gleich GJ, Flavahan NA, Fujisawa T, Vanhoutte PM. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J Allergy Clin Immunol 1988; 81:776-81.
11. Hara T, Jung LKL, Bjoirndahl JM, Fu SM. Human T cell activation III. Rapid induction of a phosphorylated 28 Kd/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens and antigens. J Exp Med 1986; 164:1988-2005.
12. Risso A, Smilovich D, Capra MC, Baldissarro I, Van G, Bargellesi A, Cosulich ME. CD69 in resting and activated T lymphocytes. Its association with a GTPbinding protein and biological requirements for its expression. J Immunol 1991; 146:4105-14.
13. Hartnell A, Robinson DS, Kay AB, Wardlaw AJ. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 1993; 80:281-6.
14. Valerius T, Repp R, Kalden JR, Platzer E. Effects of IFN on human eosionophils in comparison with other cytokines. A novel class of eosinophil activation with delayed onset of action. J Immunol 1990; 145:2950-8.
15. Fujisawa TR, Abu-Ghazaleh R, Kita H., Sanderson CJ, Gleich GJ. Regulatory effect of cytokines on eosinophil degranulation. J Immuol 1990; 144:642-6.
16. Ochiai K, Iwamoto I, Takahashi H, Yoshida S, Tomioka H, Yoshida S. Effect of Interleukin-4 and interferon-γ on interleukin-3- and interleukin-5-induced eosinophil differentiation from human cord blood mononuclear cells. Clin Exp Immunol 1995; 99:124-8.
17. Ochiai K, Kagami M, Matsumura R, Tomioka H. IL-5 but not IFN-γ inhibits eosinophil apoptosis by upregulation of bcl-2 expression. Clin Exp Immunol 1997; 107:198-204.
18. Hahn T, Barak Y, Liebovich E, Malach L, Dagan O, Rubinstein E. Ciprofloxacin inhibits human hematopoietic cell growth: synergism with tumor necrosis factor and interferon. Exp Hematol 1991; 19:157-60.
19. Wangoo A, Taylor IK, Haynes AR, Shaw RJ. Up-regulation of alveolar macrophage platelet-derived growth factor-B (PDGF-B) mRNA by interferon-gamma from Mycobacterium tuberculosis antigen (PPD)-stimulated lymphocytes. Clin exp Immunol 1993; 94:43-50.
20. Byron KA, Liberatos S, Varigos GA, Wootton AM. Interferon-gamma production in atopic dermatitis: a role for prostaglandins? Int Arch Allergy Immunol 1992; 99:50-5.
21. Sheehan KC, Calderon J, Schreiber RD. Generation and characterization of monoclonal antibodies specific for the human IFN-gamma receptor. J Immunol 1988; 140:4231-7.
22. Hershey GK, Schreiber RD. Biosynthetic analysis of the human interferon-gamma receptor. Identification of N-linked glycosylation intermediates. J Biol Chem 1989; 264:11081-8.
23. Gumina RJ, Freire-Moar J, DeYoung L, Webb DR, Devens BH. Transduction of the IFN-gamma signal for HLA-DR expression in the promonocytic line THP-1 involves a late-acting PKC activity. Cell Immunol 1991; 138:265-79.
24. Peyman JA, Hammond GL. Localization of IFN-gamma receptor in first trimester placenta to trophoblasts but lack of stimulation of HLA-DRA, -DRB, or invariant chain mRNA expession by IFN-gamma. J Immunol 1992; 149:2675-80.
25. Greenlund AC, Schreiber RD, Goeddel DV, Pennica D. Interferon-gamma induces receptor dimerization in solution and on cells. J Biol Chem 1993; 268:18103-10.
26. Ochiai K, Iwamoto I, Takahashi H, Yoshida S, Nakagawa N, Tomioka H, Yoshida S. Characteristics of an anti-eosinophil monoclonal antibody that recognizes granulocytes from patients with blood eosinophilia but not from subjects without eosinophilia. Clin exp Immunol 1991; 84:283-8.
27. Hansel TT, Pound JD, Pilling D, Kitas GD, Salmon M, Gentle TA, Lee SS, Thompson RA. Purification of human blood eosinophils by negative selection using immunomagnetic beads. J Immunol Methods 1989; 122:97-103.
28. Scathard G. The attractions of proteins for small molecules and ions. Ann NY Aci 1949; 51:660.
29. Munson PJ, Rodbard D. LIGAND: aversatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107:220-39.
30. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76:241-51.
31. Finbloom DS, Hoover DL, Wahl LM. The characteristics of binding of human recombinant interferon-gamma to its receptor on human monocytes and human monocyte-like cell lines. J Immunol 1985; 135:300-5.
32. Valente G, Ozmen L, Novelli F, Geuna M, Palestro G, Forni G, Garotta G. Distribution of interferon-γ receptor in human tissues. Eur J Immunol 1992; 22:2403-12.